In the kidneys of the Gal-3 wild-type mice treated with CIS, a notable increase in LC3B concentrations was observed in comparison to Gal-3 wild-type sham control mice (p < 0.001) (Figure 4A). This evidence concerns the gene MAP1LC3B and in situ carcinoma.